Advertisement

Health of the Individual and the Society

  • José Luis Iparraguirre
Chapter

Abstract

This chapter describes the interactions between economics, individual and population ageing, and health, healthcare, and health systems. Topics related primarily with an individual’s health covered in this chapter include economic models of demand for healthcare, health insurance, and adherence. Topics related to societal health covered in this chapter include public spending on health, a discussion of the so-called ‘red herring’ hypothesis, and comments about increasing life expectancy and quality of life.

References

  1. Abel-Smith, Brian, and Richard Titmuss. The Cost of the National Health Service in England and Wales. Cambridge: Cambridge University Press, 1956.Google Scholar
  2. Alexa, Ioana Dana et al. “Non-compliance in a large population of elderly patients with cardiovascular disease.” Medica: A Journal of Clinical Medicine 1, no. 3 (2006): 4–18.Google Scholar
  3. Aragón, Maria José, Martin Chalkley and Nigel Rice. “Medical spending and hospital inpatient care in England: An analysis over time.” Fiscal Studies 37, no. 3–4 (2016): 405–432.CrossRefGoogle Scholar
  4. Arrow, Kenneth J. “Uncertainty and the welfare economics of medical care.” American Economic Review 13, no. 5 (1963): 941–973.Google Scholar
  5. Arsenijevic, Jelena et al. “A review of health promotion funding for older adults in Europe: A cross-country comparison.” BMC Health Services Research 16, no. 5 (2016): 288. https://doi.org/10.1186/s12913-016-1515-2
  6. Baal, Pieter H. van, and Albert Wong. “Time to death and the forecasting of macro-level health care expenditures: Some further considerations.” Journal of Health Economics 31, no. 6 (2012): 876–887.CrossRefGoogle Scholar
  7. Baird, Katherine. “High out-of-pocket medical spending among the poor and elderly in nine developed countries.” Health Services Research 51, no. 4 (2016): 1467–1488.CrossRefGoogle Scholar
  8. Banks, James, Soumaya Keynes, and James P. Smith. “Health, disability and mortality differences at older ages between the US and England.” Fiscal Studies 37, no. 3–4 (2016): 345–369.CrossRefGoogle Scholar
  9. Bardenheier, Barbara H. et al. “Disability-free life-years lost among adults aged ≥50 years with and without diabetes.” Diabetes Care 39, no. 7 (2016): 1222–1229.CrossRefGoogle Scholar
  10. Barer, M. et al. “Aging and health care utilization: new evidence on old fallacies.” Social Science & Medicine 24, no. 10 (1987): 851–862.CrossRefGoogle Scholar
  11. Beltrán-Sánchez, Hiram, Fahad Razak, and S.V. Subramanian. “Going beyond the disability- based morbidity definition in the compression of morbidity framework.” Global Health Action 7 (2014). http://dx.doi.org/10.3402/gha.v7.24766 CrossRefGoogle Scholar
  12. Bergman, Bo, Duncan Neuhauser, and Lloyd Provost. “Five main processes in healthcare: A citizen perspective.” BMJ Quality & Safety Supplement 1 20 (2011): i41–i42.CrossRefGoogle Scholar
  13. Bernoulli, Daniel. “Exposition of a new theory on the measurement of risk.” Econometrica 22, no. 1 (1954): 23–36.CrossRefGoogle Scholar
  14. Bíró, Anikó. “Copayments, gatekeeping, and the utilization of outpatient public and private care at age 50 and above in Europe.” Health Policy 111, no. 1 (2013): 24–33.CrossRefGoogle Scholar
  15. Blaxter, Mildred. Health Key Concepts. Cambridge: Polity Press, 2010.Google Scholar
  16. Bosworth, Hayden. “Introduction.” In: Improving Patient Treatment Adherence A Clinician’s Guide. Edited by Hayden Bosworth, 1–8. New York, NY: Springer, 2010.Google Scholar
  17. Breyer, Friedrich, Normann Lorenz, and Thomas Niebel. “Health care expenditures and longevity: Is there a Eubie Blake effect?” The European Journal of Health Economics 16, no. 1 (2015): 95–112.CrossRefGoogle Scholar
  18. Brownlee, Shannon et al. “Evidence for overuse of medical services around the world.” The Lancet (2017). https://doi.org/10.1016/S0140-6736(16)32585-5 CrossRefGoogle Scholar
  19. Buchanan, Allen. “Principal/agent theory and decisionmaking in health care.” Bioethics 2, no. 4 (1988): 317–333.CrossRefGoogle Scholar
  20. Burns, Jonathan K., Andrew Tomita, and Amy S. Kapadia. “Income inequality and schizophrenia: Increased schizophrenia incidence in countries with high levels of income inequality.” International Journal of Social Psychiatry 60, no. 2 (2014): 185–196.CrossRefGoogle Scholar
  21. Caley, Michael, and Khesh Sidhu. “Estimating the future healthcare costs of an aging population in the UK: Expansion of morbidity and the need for preventative care.” Journal of Public Health 33, no. 1 (2011): 117–122.CrossRefGoogle Scholar
  22. Cardozo, Cláudia. “Health economics or health care economics?” Revista de Estudios Politécnicos Polytechnical Studies Review VI, no. 10 (2008): 189–198.Google Scholar
  23. Case, Anne, and Angus, Deaton. “Broken down by work and sex: How our health declines.” In Analyses in the Economics of Aging NBER Conference Report. Edited by David A. Wise, 185–212. Chicago, IL: University of Chicago Press. 2005.Google Scholar
  24. Chang, Hong et al. “Further evidence of VRK2 rs2312147 associated with schizophrenia.” The World Journal of Biological Psychiatry 17, no. 6 (2016): 457–466.CrossRefGoogle Scholar
  25. Charlesworth, Christina J. et al. “Polypharmacy among adults aged 65 years and older in the United States: 1988–2010.” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 70 (2015): 989–995.CrossRefGoogle Scholar
  26. Chatterji, Somnath et al. “Health, functioning, and disability in older adults-present status and future implications.” The Lancet 385, no. 9967 (2015): 563–575.CrossRefGoogle Scholar
  27. Chiang, Alpha C. Fundamental Methods of Mathematical Economics. New York, NY: McGraw-Hill. 1984.Google Scholar
  28. Chodick, Gabriel, Sarah Sharman Moser, and Inbal Goldshtein. “Non-adherence with biphosphonates among patients with osteoporosis: Impact on fracture risk and healthcare cost.” Expert Review of Pharmacoeconomics & Outcomes Research 16, no. 3 (2016): 359–370.CrossRefGoogle Scholar
  29. Clark, Stephen D., and Philip H. Rees. “The drivers of health trends: A decomposition of projected health for local areas in England.” In The Frontiers of Applied Demography. Edited by David A. Swanson. Applied Demography Series, vol. 9, 21–40. Cham: Springer. 2017.Google Scholar
  30. Codish, Shlomi, and Richard N. Shiffman. “A model of ambiguity and vagueness in clinical practice guideline recommendations.” In AMIA Annual Symposium Proceedings, vol. 2005, 146–150. Bethesda, MD: American Medical Informatics Association. 2005.Google Scholar
  31. Colombier, Carsten. “Population ageing in healthcare a minor issue? Evidence from Switzerland.” Applied Economics (2017) 1–15. https://doi.org/10.1080/00036846.2017.1374538 CrossRefGoogle Scholar
  32. Commission on Social Determinants of Health. Closing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health. Geneva: World Health Organization. 2008.Google Scholar
  33. Conrad, Douglas A., and Sean D. Sullivan. “Health economics.” In Encyclopedia of Biostatistics. Edited by Peter Armitage and Theodore Colton. 2nd ed. Hoboken, NJ: Wiley. 2005.Google Scholar
  34. Costa, Filipa Alves da et al. “Effects of economic recession on elderly patients’ perceptions of access to health care and medicines in Portugal.” International Journal of Clinical Pharmacy 39, no. 1 (2017): 104–112.Google Scholar
  35. Coulson, N. Edward et al. Estimating the moral-hazard effect of supplemental medical insurance in the demand for prescription drugs by the elderly. The American Economic Review 85, no. 2 (1995): 122–126.Google Scholar
  36. Covello, Vincent T., and Miley W. Merkhofer. Risk Assessment Methods: Approaches for Assessing Health and Environmental. New York, NY: Springer. 1993.CrossRefGoogle Scholar
  37. Cropper, Maureen L. “Health, investment in health, and occupational choice.” The Journal of Political Economy 85, no. 6 (1977): 1273–1294.CrossRefGoogle Scholar
  38. Cullis, John G., and Peter A. West. The Economics of Health: An Introduction. New York, NY: New York University Press. 1979.Google Scholar
  39. Culyer, Anthony J. The Dictionary of Health Economics. Cheltenham: Edward Elgar Publishing. 2005.Google Scholar
  40. Curtis, Lesley H. et al. “The insurance effect on prescription drug expenditures among the elderly: Findings from the 1997 medical expenditure panel survey.” Medical Care 42, no. 5 (2004): 439–446.Google Scholar
  41. Cutler, David M., and Mark McClellan. “Is technological change in medicine worth it?” Health Affairs 20, no. 5 (2001): 11–29.CrossRefGoogle Scholar
  42. Cutler, David M., Wei Huang, and Adriana Lleras-Muney. Economic Conditions and Mortality: Evidence from 200 Years of Data. NBER Working Paper 22690. Cambridge, MA: National Bureau of Economic Research. 2016.CrossRefGoogle Scholar
  43. Dahlgren, Göran, and Margaret Whitehead. Policies and Strategies to Promote Social Equity in Health. Background Document to WHO Strategy Paper for Europe. Stockholm: Sweden. 1991.Google Scholar
  44. Dalgaard, Carl-Johan, and Holger Strulik. “Optimal aging and death: Understanding the Preston curve.” Journal of the European Economic Association 12, no. 3 (2014): 672–701.CrossRefGoogle Scholar
  45. —. “The economics of health demand and human aging: Health capital vs health deficits.” 2015. http://holger-strulik.org/my_papers/health_capital_deficits.pdf
  46. Danczak, A., and A. Lea. Mapping Uncertainty in Medicine: What to Do When You Don’t Know What to Do? London: Royal College of General Practitioners. 2016.Google Scholar
  47. Dardanoni, Valentino, and Adam Wagstaff. “Uncertainty inequalities in health and the demand for health.” Journal of Health Economics 6, no. 4 (1987): 283–290.CrossRefGoogle Scholar
  48. —. “Uncertainty and the demand for medical care.” Journal of Health Economics 9, no. 1 (1990): 23–38.CrossRefGoogle Scholar
  49. Deleuze, Giles, and Félix Guattari. Anti-Oedipus. Capitalism and Schizophrenia. London: Bloomsbury Academic. 2004.Google Scholar
  50. Delgado, Melvin. Older Adult-led Health Promotion in Urban Communities: Models and Interventions. Plymouth: Rowman & Littlefield Publishers. 2008.Google Scholar
  51. De Meza, David. “Health insurance and the demand for medical care.” Journal of Health Economics 2, no. 1 (1983): 47–54.CrossRefGoogle Scholar
  52. Dormont, Brigitte, Michel Grignon, and Hélène Huber. “Health expenditure growth: Reassessing the threat of ageing.” Health Economics 15, no. 9 (2006): 947–963.CrossRefGoogle Scholar
  53. Dowie, Jack. “The portfolio approach to health behavior.” Social Science & Medicine 9 (1975): 619–631.CrossRefGoogle Scholar
  54. Doyle, Conor Simon White, and Lizzie Mills. “Adherence with oral chemotherapy in a cancer unit in Northern Ireland.” Journal of Medicines Optimisation 2, no. 2 (2016): 28–33.Google Scholar
  55. Dwyer, Peter. “Retired EU migrants, healthcare rights and European social citizenship.” The Journal of Social Welfare & Family Law 23, no. 3 (2001): 311–327.CrossRefGoogle Scholar
  56. Eddy, David, M. “Variations in physician practice: The role of uncertainty.” Health Affairs 3, no. 2 (1984): 74–89.CrossRefGoogle Scholar
  57. Edwards, R.T. “Paradigms and research programmes: Is it time to move from health care economics to health economics?” Health Economics 10, no. 7 (2001), 635–650.CrossRefGoogle Scholar
  58. Elkeles, Thomas, and Andreas Mielck. “Entwicklung Eines Modells Zur Erklärung Gesund- heitlicher Ungleichheit.” Gesundheitswesen 59, no. 3 (1997): 137–143.Google Scholar
  59. Elliott, R., and K. Payne. Essentials of Economic Evaluation in Healthcare. London: Pharmaceutical Press. 2005.Google Scholar
  60. Fabbri, Daniele, and Chiara Monfardini. “Public vs. private health care services demand in Italy.” Giornale Degli Economisti e Annali di Economia 62, no. 1 (2003): 93–123.Google Scholar
  61. Fang, Hai, and John A. Rizzo. “Competition and physician-enabled demand: The role of managed care.” Journal of Economic Behavior & Organization 72, no. 1 (2009): 463–474.CrossRefGoogle Scholar
  62. Felder Stefan, Andreas Werblow, and Peter Zweifel. “Do red herrings swim in circles? Controlling for the endogeneity of time to death.” Journal of Health Economics 29, no. 2 (2010): 205–212.CrossRefGoogle Scholar
  63. Fogel, Robert W. Changes in the Process of Aging During the Twentieth Century: Findings and Procedures of the Early Indicators Project. NBER Working Paper 9941. Cambridge, MA: National Bureau of Economic Research. 2003.Google Scholar
  64. Folland, Sherman, Allen C. Goodman, and Miron Stano. The Economics of Health and Health Care. Pearson International Edition. New Jersey, NJ: Prentice Hall. 2016.Google Scholar
  65. Forma, Leena et al. “Age and closeness of death as determinants of health and social care utilization: A case-control study.” The European Journal of Public Health 19, no. 3 (2009): 313–318.CrossRefGoogle Scholar
  66. Fries, James F. “Aging, natural death, and the compression of morbidity.” The New England Journal of Medicine 303, no. 3 (1980): 130–135.CrossRefGoogle Scholar
  67. Fries, James F., Bonnie Bruce, and Eliza Chakravarty. “Compression of morbidity 1980–2011: A focused review of paradigms and progress.” Journal of Aging Research 2011 (2011): Article ID 261702.CrossRefGoogle Scholar
  68. Fuchs, Victor R. Who Shall Live? Health, Economics, and Social Choice. Economic Ideas Leading to the 21st Century Singapore, vol. 3. Singapore: World Scientific. 1998.Google Scholar
  69. Fukawa, Tetsuo. “Inpatient expenditure of the decedent elderly in Japan.” British Journal of Medicine & Medical Research 15, no. 10 (2016): 1–10.CrossRefGoogle Scholar
  70. Fukushima, Kazuya et al. “Patient cost sharing and medical expenditures for the elderly.” Journal of Health Economics 45 (2016): 115–130.CrossRefGoogle Scholar
  71. Gastaldi-Ménager Christelle, Pierre-Yves Geoffard, and Grégoire de Lagasnerie. “Medical spending in France: Concentration, persistence and evolution before death.” Fiscal Studies 37, no. 3–4 (2016): 499–526.Google Scholar
  72. Gavrilov, Leonid A., and Natalia S. Gavrilova. “Models of systems failure in aging.” In Handbook of Models for Human Aging. Edited by P. Michael Conn, 45–68. Burlington, MA: Elsevier Academic Press. 2006.Google Scholar
  73. Gaziano, Thomas A., and J. Michael Gaziano. “Global evolving epidemiology natural history and treatment trends of myocardial infarction.” In Myocardial Infarction: A Companion to Braunwald’s Heart Disease. Edited by David A. Morrow, 11. St Louis, MO: Elsevier. 2016.Google Scholar
  74. Gee, Ellen M. “Misconceptions and misapprehensions about population ageing.” International Journal of Epidemiology 31, no. 4 (2002): 750–753.CrossRefGoogle Scholar
  75. General Assembly of the United Nations. Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. New York, NY: United Nations. 2011.Google Scholar
  76. Geue, Claudia et al. “Population ageing and healthcare expenditure projections: New evidence from a time to death approach.” The European Journal of Health Economics 15, no. 8 (2014): 885–896.CrossRefGoogle Scholar
  77. Geyer, S. “Die Morbiditätskompressionsthese und ihre Alternativen.” Das Gesund- heitswesen 77, no. 06 (2015): 442–446.Google Scholar
  78. Giardini, Anna et al. “Toward appropriate criteria in medication adherence assessment in older persons: Position paper.” Aging Clinical and Experimental Research 28, no. 3 (2016): 371– 381.CrossRefGoogle Scholar
  79. Glynn, Liam G. et al. “The prevalence of multimorbidity in primary care and its effect on health care utilization and cost.” Family Practice 28, no. 5 (2011): 516–523.CrossRefGoogle Scholar
  80. Grossman, Michael. “On the concept of health capital and the demand for health.” Journal of Political Economy 80, no. 2 (1972): 223–255.CrossRefGoogle Scholar
  81. —. “The human capital model.” In Handbook of Health Economics. Edited by Anthony J. Culyer and Joseph P Newhouse, vol. 1A, 347– 408. Amsterdam: Elsevier. 2000.Google Scholar
  82. —. “The relationship between health and schooling: What’s new?” Nordic Journal of Health Economics 3, no. 1 (2015): 7–17.CrossRefGoogle Scholar
  83. Gruber, Stefan, and Markus Kiesel. “Inequality in health care utilization in Germany? Theoretical and empirical evidence for specialist consultation.” Journal of Public Health 18 (2010): 351–365.CrossRefGoogle Scholar
  84. Gruenberg, Ernest M. “The failures of success.” The Milbank Memorial Fund Quarterly Health and Society 55 (1977): 3–24.CrossRefGoogle Scholar
  85. Haber, David. Health Promotion and Aging Practical Applications for Health Professionals. New York, NY: Springer. 2013.Google Scholar
  86. Han, Paul K., William M. Klein, and Neeraj K. Arora. “Varieties of uncertainty in health care: A conceptual taxonomy.” Medical Decision Making 31, no. 6 (2011): 828–838.CrossRefGoogle Scholar
  87. Harris, Anthony, and Anurag Sharma. The Future of Health and Aged Care Expenditure in Australia. CSIRO-Monash Working Paper 2016-05. 2016.Google Scholar
  88. Hauck, Katharina, and Xiaohui Zhang. “Heterogeneity in the effect of common shocks on healthcare expenditure growth.” Health Economics 25 (2016): 1090–1103.CrossRefGoogle Scholar
  89. Healthcare Intelligence Network. 2010 Benchmarks in Improving Medication Adherence. Sea Girt, NJ: Healthcare Intelligence Network. 2010.Google Scholar
  90. Henderson, John, Alistair Mcguire, and Gavin Mooney. Economics of Health Care. New York, NY: Taylor & Francis. 2005.CrossRefGoogle Scholar
  91. Hennessy, Deirdre et al. “Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease.” Health Reports 27, no. 6 (2016): 3–8.Google Scholar
  92. Herr, M. et al. “Polypharmacy and frailty: Prevalence, relationship, and impact on mortality in a French sample of 2350 old people.” Pharmaco Epidemiology and Drug Safety 24, no. 6 (2015): 637–646.CrossRefGoogle Scholar
  93. Herzlich, Claudine. Santé et Maladie: Analyse d’une Representation Sociale. Paris: Éditions Mouton. 1969.Google Scholar
  94. Hoffmann, Rasmus. Socioeconomic Differences in Old Age Mortality. The Springer Series on Demographic Methods and Population Analysis. Dordrecht: Springer. 2008.CrossRefGoogle Scholar
  95. Hugonnier, Julien, Florian Pelgrin, and Pascal St-Amour. “Health and (other) asset holdings.” The Review of Economic Studies 80, no. 2 (2013): 663–710.CrossRefGoogle Scholar
  96. Hurley, Jeremiah. “An overview of the normative economics of the health sector.” In Handbook of Health Economics. Edited by Anthony J. Culyer and Joseph P. Newhouse. Handbook of Health Economics, 55–118. Amsterdam: Elsevier. 2000.Google Scholar
  97. Hutt, William H. “The concept of consumers’ sovereignty.” The Economic Journal 50, no. 197 (1940): 66–77.CrossRefGoogle Scholar
  98. Jacobson, Mireille et al. Physician Agency and Competition: Evidence from a Major Change to Medicare Chemotherapy Reimbursement Policy.” Working Paper No 19247. National Bureau of Economic Research. 2013.Google Scholar
  99. Jacobson, Mireille G. et al. “Physician agency and patient survival.” Journal of Economic Behavior & Organization 134 (2017): 27–47.CrossRefGoogle Scholar
  100. Jagger, Carol et al. “A comparison of health expectancies over two decades in England: Results of the cognitive function and ageing study I and II.” The Lancet 387, no. 10020 (2016): 779–786.CrossRefGoogle Scholar
  101. Jiménez-Martín, Sergi, José M Labeaga, and Maite Martínez-Granado. “An empirical analysis of the demand for physician services across the European Union.” The European Journal of Health Economics 5, no. 2 (2004): 150–165.Google Scholar
  102. Jofre-Bonet, Mireia. “Health care: Private and/or public provision.” European Journal of Political Economy 16, no. 3 (2000a): 469–489.CrossRefGoogle Scholar
  103. —. “Public health care and private insurance demand: The waiting time as a link.” Health Care Management Science 3, no. 1 (2000b): 51–71.Google Scholar
  104. Jokanovic, Natali et al. “Prevalence and factors associated with polypharmacy in long-term care facilities: A systematic review.” Journal of the American Medical Directors Association 16, no. 6 (2015): 535:e1–535:e12.CrossRefGoogle Scholar
  105. Jones, Andrew, and Roberto Zanola. “Agency and health care.” In Public Decision-Making Processes and Asymmetry of Information. Edited by Massimo Marrelli and Giacomo Pignataro, 165–188. Norwell, MA: Kluwer. 2001.Google Scholar
  106. Jorgenson, Dale W. “Capital theory and investment behavior.” The American Economic Review 53, no. 2 (1963): 247–259.Google Scholar
  107. Kannisto, Vaino. “Mode and dispersion of the length of life.” Population: An English Selection Biodemographic Perspectives on Human Longevity 13 (2001): 159–171.Google Scholar
  108. Karlsson, Martin, and Florian Klohn. “Testing the red herring hypothesis on an aggregated level: Ageing, time-to-death and care costs for older people in Sweden.” The European Journal of Health Economics 15, no. 5 (2014): 533–551.CrossRefGoogle Scholar
  109. Karlsson, Martin, Tobias J. Klein, and Nicolas R. Ziebarth. “Skewed, persistent and high before death: Medical spending in Germany.” Fiscal Studies 37, no. 3–4 (2016): 527–559.CrossRefGoogle Scholar
  110. Kirkman, M. Sue et al. “Determinants of adherence to diabetes medications: Findings from a large pharmacy claims database.” Diabetes Care 38, no. 4 (2015): 604–609.Google Scholar
  111. Knight, Frank H. Risk, Uncertainty and Profit. Boston: MA: Houghton Mifflin Co. 1921.Google Scholar
  112. Kong, Augustine et al. “How medical professionals evaluate expressions of probability.” New England Journal of Medicine 315, no. 12 (1986): 740–744.CrossRefGoogle Scholar
  113. Kowald, Axel. “Lifespan does not measure ageing.” Biogerontology 3, no. 3 (2002): 187–190.CrossRefGoogle Scholar
  114. Laffont, Jean Jacques. The Principal Agent Model: The Economic Theory of Incentives. Princeton, NJ: Princeton University Press. 2002.Google Scholar
  115. Laporte, Audrey. Should the Grossman Model of Investment in Health Capital Retain its Iconic Status? Working Paper 04. Canadian Centre for Health Economics Centre Canadien en Économie de la Santé. 2015.Google Scholar
  116. Laporte, Audrey, and Brian S. Ferguson. “Investment in health when health is stochastic.” Journal of Population Economics 20, no. 2 (2007): 423–444.CrossRefGoogle Scholar
  117. Lau, Ying et al. “Multidimensional factors affecting medication adherence among community-dwelling older adults: A structural-equation-modeling approach.” Journal of Public Health 25, no. 1 (2017): 113–122.CrossRefGoogle Scholar
  118. Lee, Ronald, and Timothy Miller. “An approach to forecasting health expenditures, with application to the US medicare system.” Health Services Research 37, no. 5 (2002): 1365–1386.CrossRefGoogle Scholar
  119. Lee, Ronald, and Shripad Tuljapurkar. “Death and Taxes: Longer life, consumption, and social security.” Demography 34, no. 1 (1997): 67–81.CrossRefGoogle Scholar
  120. Lee, Ronald, Andrew Mason, and Daniel Cotlear. Some Economic Consequences of Global Aging: A Discussion Note for the World Bank. Health, Nutrition and Population (HNP) Discussion Paper. Washington, DC: The World Bank. 2010.Google Scholar
  121. Léonard, Christian, Sabine Stordeur, and Dominique Roberfroid. “Association between physician density and health care consumption: A systematic review of the evidence.” Health Policy 91, no. 2 (2009): 121–134.CrossRefGoogle Scholar
  122. Lim, Li Min et al. “Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia.” PLoS One 12, no. 3 (2017).  https://doi.org/10.1371/journal.pone.0173466 CrossRefGoogle Scholar
  123. Lima, de et al. “Social determinants of death among the elderly: A systematic literature review.” Revista Brasileira de Epidemiologia 17 (2014): 178–193.CrossRefGoogle Scholar
  124. Liu, Xingzhu, and Anne Mills. “Agency theory and its applications in health care.” In Public Ends, Private Means. Strategic Purchasing of Health Services. Edited by Alexander S. Preker et al., 151–178. Washington, DC: The World Bank. 2007.Google Scholar
  125. Longman, Philip. Born to Pay: The New Politics of Aging in America. Boston: Houghton Mifflin. 1987.Google Scholar
  126. Ludbrook, Anne, and David Cohen. “Economics of health and health improvement.” In Advances in Health Economics. Edited by Alan Maynard Anthony Scott and Robert Elliott, 223–240. Chichester: Wiley. 2003.Google Scholar
  127. Mackenbach, Johan P. “Socioeconomic inequalities in health in high income countries: The facts and the options.” In Oxford Textbook of Global Public Health. Edited by Rogers Detels et al., vol. 1, 106–126. Oxford: Oxford University Press. 2015.CrossRefGoogle Scholar
  128. Maeda, Toshiki et al. “Investigation of the existence of supplier-induced demand in use of gastrostomy among older adults: A retrospective cohort study.” Medicine 95, no. 5 (2016): 1–7.CrossRefGoogle Scholar
  129. Malehi, Amal Saki, Fatemeh Pourmotahari, and Kambiz Ahmadi Angali. “Statistical models for the analysis of skewed healthcare cost data: A simulation study.” Health Economics Review 5, no. 1–16 (2015), 11.Google Scholar
  130. Manton, Kenneth G. “Changing concepts of morbidity and mortality in the elderly population.” The Milbank Memorial Fund Quarterly Health and Society 60 (1982): 183–244.CrossRefGoogle Scholar
  131. Marshall, John M. “Moral hazard.” The American Economic Review 66, no. 5 (1976): 880– 890.Google Scholar
  132. Marshall, Alfred. Principles of Economics. Palgrave Classics in Economics. Basingstoke: Palgrave Macmillan. 2013.CrossRefGoogle Scholar
  133. Martín-Pérez, M. et al. “Prevalence of polypharmacy among the population older than 65 years in Spain: Analysis of the 2006 and 2011/12 national health surveys.” Revista Española de Geriatría y Gerontología 52, no. 1 (2017): 2–8.Google Scholar
  134. Mason, Thomas et al. “Exploring the limitations of age-based models for health care planning.” Social Science & Medicine 132 (2015): 11–19.CrossRefGoogle Scholar
  135. McGuire, Thomas G. “Physician agency.” In Handbook of Health Economics. Edited by Anthony J. Culyer and Joseph P Newhouse, vol. 1, 461–536. Amsterdam: Elsevier. 2000Google Scholar
  136. McGuire, Thomas G., and Mark V. Pauly. “Physician response to fee changes with multiple payers.” Journal of Health Economics 10, no. 4 (1991): 385–410.CrossRefGoogle Scholar
  137. McMaster Robert. “On the need for a heterodox health economics.” Post-autistic Economics Review 41 (2007): 9–22.Google Scholar
  138. McPake, Barbara, Charles Normand, and Samantha Smith. Health Economics: An Interna-tional Perspective. Durham Modern Middle East and Islamic World. New York, NY: Taylor & Francis. 2013.Google Scholar
  139. Meijer, Claudine de et al. “The effect of population aging on health expenditure growth: A critical review.” European Journal of Ageing 10, no. 4 (2013): 353–361.CrossRefGoogle Scholar
  140. Meyer, Stefan. “Dispensing physicians, asymmetric information supplier-induced demand: Evidence from the Swiss Health Survey.” International Journal of Health Economics and Management 16, no. 3 (2016): 215–245.CrossRefGoogle Scholar
  141. Mohanty, Sanjay K. et al. “Out-of-pocket expenditure on health care among elderly and non-elderly households in India.” Social Indicators Research 115, no. 3 (2014): 1137–1157.CrossRefGoogle Scholar
  142. Moore, Patrick V., Kathleen Bennett, and Charles Normand. “Counting the time lived, the time left or illness? Age, proximity to death, morbidity and prescribing expenditures.” Social Science & Medicine 184 (2017): 1–14.CrossRefGoogle Scholar
  143. Morris, Stephen, Nancy Devlin, and David Parkin. Economic Analysis in Health Care. Chichester: Wiley. 2007.Google Scholar
  144. Morrisey, Michael A., and John Cawley. “Health economists’ views of health policy.” Journal of Health Politics, Policy and Law 33, no. 4 (2008): 707–724.CrossRefGoogle Scholar
  145. Muschik, Denise et al. “Morbidity compression, morbidity expansion, or dynamic equilibrium? The time trend of AOK-insured patients with type 2 diabetes in lower Saxony Germany.” Journal of Public Health 25 (2016): 1–10.Google Scholar
  146. Mushkin, Selma J. “Health as an Investment.” The Journal of Political Economy 70 (1962): 129–157.CrossRefGoogle Scholar
  147. Muurinen, Jaana-Marja. “Demand for health: A generalised Grossman model.” Journal of Health Economics 1, no. 1 (1982): 5–28.CrossRefGoogle Scholar
  148. Muurinen, Jaana-Marja, and Julian Le Grand. “The economic analysis of inequalities in health.” Social Science & Medicine 20, no. 10 (1985): 1029–1035.CrossRefGoogle Scholar
  149. Nagl, Alexander et al. “Relationship between multimorbidity and direct healthcare costs in an advanced elderly population.” Zeitschrift für Gerontologie und Geriatrie 45, no. 2 (2012): 146–154.CrossRefGoogle Scholar
  150. Nardi, Mariacristina et al. “Medical spending of the US elderly.” Fiscal Studies 37, no. 3–4 (2016): 717–747.Google Scholar
  151. NCD Risk Factor Collaboration. “Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants.” The Lancet 387, no. 10027 (2016): 1513–1530.Google Scholar
  152. NEHI. Thinking Outside the Pillbox. A System-Wide Approach to Improving Patient Medication Adherence for Chronic Disease. NEHI Research Brief. Cambridge, MA: New England Health Care Institute. 2009.Google Scholar
  153. Nguyen, Louis et al. “Provider-induced demand in the treatment of carotid artery stenosis: Variation in treatment decisions between private sector fee-for-service vs salary-based military physicians.” JAMA Surgery (2017).  https://doi.org/10.1001/jamasurg.2017.0077 CrossRefGoogle Scholar
  154. NIHCM. The Concentration of Health Care Spending. NIHCM Foundation Data Brief. Washington, DC: National Institute for Health Care Management Research and Educational Foundation. 2012.Google Scholar
  155. Nishtala, Prasad S., and Mohammed Saji Salahudeen. “Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005–2013.” Gerontology 61, no. 3 (2015): 195–202.CrossRefGoogle Scholar
  156. Nusselder, Wilma J. et al. “The elimination of selected chronic diseases in a population: The compression and expansion of morbidity.” American Journal of Public Health 86, no. 2 (1996): 187–194.CrossRefGoogle Scholar
  157. Nyman, John A. “The economics of moral hazard revisited.” Journal of Health Economics 18, no. 6 (1999): 811–824CrossRefGoogle Scholar
  158. —. “The income transfer effect, the access value of insurance and the Rand health insurance experiment.” Journal of Health Economics 20, no. 2 (2001): 295–298.CrossRefGoogle Scholar
  159. —. “Evaluating health insurance: A review of the theoretical foundations.” The Geneva Papers on Risk and Insurance Issues and Practice 31, no. 4 (2006): 720–738.CrossRefGoogle Scholar
  160. Olshanksy, S. Jay. “Big claims and bold characters.” Health Affairs 33, no. 5 (2014): 901–903.CrossRefGoogle Scholar
  161. Olshansky, S. Jay et al. “Trading off longer life for worsening health the expansion of morbidity hypothesis.” Journal of Aging and Health 3, no. 2 (1991): 194–216.CrossRefGoogle Scholar
  162. Olshansky, S. Jay, Leonard Hayflick, and Bruce A. Carnes. “Position statement on human aging.” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 57, no. 8 (2002a): B292–B297.CrossRefGoogle Scholar
  163. Olshansky, S. Jay, Leonard Hayflick, and Bruce A. Carnes. “No truth to the fountain of youth.” Scientific American 286, no. 6 (2002b): 92–95.CrossRefGoogle Scholar
  164. O’Neill, Desmond. “Protecting the global longevity dividend.” The Lancet. Global Health 5, no. 2 (2017): e116–e117.CrossRefGoogle Scholar
  165. ONS. What Are the Chances of Surviving to Age 100. Newport, Wales. 2010.Google Scholar
  166. Park, Eun-Ja et al. “Out-of-pocket medication expenditure burden of elderly Koreans with chronic conditions.” International Journal of Gerontology 9, no. 3 (2015): 166–171.CrossRefGoogle Scholar
  167. Parker, Marti G., and Mats Thorslund. “Health trends in the elderly population: Getting better and getting worse.” The Gerontologist 47, no. 2 (2007): 150–158.CrossRefGoogle Scholar
  168. Payne, Greg et al. “Counting backward to health care’s future: Using time-to-death modeling to identify changes in end-of-life morbidity and the impact of aging on health care expenditures.” Milbank Quarterly 85, no. 2 (2007): 213–257.CrossRefGoogle Scholar
  169. Pelgrin, Florian, and Pascal St-Amour. “Life cycle responses to health insurance status.” Journal of Health Economics 49 (2016): 76–96.CrossRefGoogle Scholar
  170. Persky, Joseph. “Retrospectives: Consumer sovereignty.” The Journal of Economic Perspectives 7, no. 1 (1993): 183–191.CrossRefGoogle Scholar
  171. Piette, John D., Michele Heisler, and Todd H. Wagner. “Problems paying out-of-pocket medication costs among older adults with diabetes.” Diabetes Care 27, no. 2 (2004): 384–391.CrossRefGoogle Scholar
  172. Polder, Johan J., Jan J. Barendregt, and Hans van Oers. “Health care costs in the last year of life-the Dutch experience.” Social Science & Medicine 63, no. 7 (2006): 1720–1731.CrossRefGoogle Scholar
  173. Prescott, Edward S. “A primer on moral-hazard models.” Federal Reserve Bank of Richmond Economic Quarterly 85, no. 1 (1999): 47–78.Google Scholar
  174. Przywara, Bartosz. Projecting Future Health Care Expenditure at European Level: Drivers, Methodology and Main Results. Economic Papers 417. Brussels: Directorate-General for Economic and Financial Affairs. European Commission. 2010.Google Scholar
  175. Robine, Jean-Marie, and Colins D. Mathers. “Measuring the compression or expansion of morbidity through changes in health expectancy.” In Calculation of Health Expectancies: Harmonization, Consensus Achieved and Future Perspectives. Edited by Jean-Marie Robine et al., 269–269. Montpellier: John Libbey Eurotext. 1993.Google Scholar
  176. Rothstein, William G. Public Health and the Risk Factor: A History of an Uneven Medical Revolution. Rochester Studies in Medical History. Rochester NY: University of Rochester Press. 2003.Google Scholar
  177. Safran, Dana Gelb et al. “Prescription drug coverage and seniors: Findings from a 2003 national survey.” Health Affairs 24 (2005): W5:152–W5:166.Google Scholar
  178. Saleh, Shadi S., Wendy Weller, and Edward Hannan. “The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.” Journal of Health and Human Services Administration 30, no. 1 (2007): 50–74.Google Scholar
  179. Salomon, Joshua A. et al. “Healthy life expectancy for 187 countries, 1990–2010: A systematic analysis for the global burden disease Study 2010.” The Lancet 380, no. 9859 (2013): 2144– 2162.CrossRefGoogle Scholar
  180. Santerre, Rexford E., and Stephen P. Neun. Health Economics: Theory Insights, and Industry Studies. Mason, OH: South-Western Cengage Learning. 2010.Google Scholar
  181. Scheil-Adlung, Xenia, and Jacopo Bonan. Can the European Elderly Afford the Financial Burden of Health and Long-Term Care? Assessing Impacts and Policy Implications. ESS (Extension of Social Security) Paper 31. Geneva: Switzerland. 2012.Google Scholar
  182. Schneider, Helen, and Alan Mathios. “Principal agency theory and health care utilization.” Economic Inquiry 44, no. 3 (2006): 429–441.CrossRefGoogle Scholar
  183. Schwartz, Andrea. Informations- und Anreizprobleme im Krankenhaussektor: Eine institu- tionenökonomische Analyse. Markt- und Unternehmensentwicklung Markets and Organisations. Wiesbaden: Springer. 1997.CrossRefGoogle Scholar
  184. Sekimoto, Miho, and Masako Ii. “Supplier-induced demand for chronic disease care in Japan: Multilevel analysis of the association between physician density and physician-patient encounter frequency.” Value in Health Regional Issues 6 (2015): 103–110.CrossRefGoogle Scholar
  185. Shakespeare, William. “The Tempest.” In The Complete Works of William Shakespeare. London: Spring Books. 1958.Google Scholar
  186. Shih, Ya-Chen Tina, and Ming Tai-Seale. “Physicians’ perception of demand-induced supply in the information age: A Latent class model analysis.” Health Economics 21 (2012): 252–269.CrossRefGoogle Scholar
  187. Shmueli, Amir et al. “Health care costs during the last 12 months of life in Israel: Estimation and implications for risk-adjustment.” International Journal of Health Care Finance and Economics 10, no. 3 (2010): 257–273.CrossRefGoogle Scholar
  188. Siegel, Jacob S. The Demography and Epidemiology of Human Health and Aging. New York, NY: Springer. 2012.CrossRefGoogle Scholar
  189. Sloan, Frank A., and Chee-Ruey Hsieh. Health Economics. Cambridge, MA: The MIT Press. 2012.Google Scholar
  190. Smith, Peter C., and Winnie Yip. “The economics of health system design.” Oxford Review of Economic Policy 32, no. 1 (2016): 21–40.CrossRefGoogle Scholar
  191. Solar, Orielle, and Alec Irwin. A Conceptual Framework for Action on the Social Determinants of Health. Geneva: World Health Organization. 2007.Google Scholar
  192. Stallard, Eric. “Compression of morbidity and mortality: New perspectives.” North American Actuarial Journal 20, no. 4 (2016): 341–354.CrossRefGoogle Scholar
  193. Standard & Poor’s. Global Aging 2013: Rising to the Challenge. Global Credit Portal. Ratings Services. New York, NY: Standard & Poor’s Financial Services LLC. 2013.Google Scholar
  194. Steensma, Colin, Lidia Loukine, and Bernard C.K. Choi. “Evaluating compression or expansion of morbidity in Canada: Trends in life expectancy and health-adjusted life expectancy from 1994 to 2010.” Chronic Diseases and Injuries in Canada 37, no. 3 (2017): 68–76.CrossRefGoogle Scholar
  195. Strulik, Holger, and Sebastian Vollmer. “Long-run trends of human aging and longevity.” Journal of Population Economics 26, no. 4 (2013): 1303–1323.CrossRefGoogle Scholar
  196. Sydsæter, Knut, Peter Hammond, and Anne Strøm. Essential Mathematics for Economic Analysis. Harlow: Pearson. 2012.Google Scholar
  197. Tamblyn, Robyn et al. “Adverse events associated with prescription drug cost-sharing among poor and elderly persons.” JAMA 285, no. 4 (2001): 421–429.CrossRefGoogle Scholar
  198. Thatcher, A., Roger Väinö Kannisto, and James W. Vaupel. The Force of Mortality at Ages 80 to 120 Monographs on Population Aging. Odense: Odense University Press. 1998.Google Scholar
  199. The Royal Society. Risk: Analysis, Perception and Management Report of a Royal Society Study Group. London: The Royal Society. 1992.Google Scholar
  200. Titterton, Mike. Risk and Risk Taking in Health and Social Welfare. Gateshead: Athenaeum Press. 2004.Google Scholar
  201. Trachte, F., S. Sperlich, and S. Geyer. “Kompression oder Expansion der Morbidität?” Zeitschrift für Gerontologie und Geriatrie 48, no. 3 (2015): 255–262.CrossRefGoogle Scholar
  202. Tur-Sinai, Aviad, and Howard Litwin. “Forgone visits to the doctor due to cost or lengthy waiting time among older adults in Europe.” In Ageing in Europe Supporting Policies for an Inclusive Society. Edited by Axel Börsch-Supan et al., 291–300. Berlin: De Gruyter. 2015.Google Scholar
  203. United Nations. World Population Ageing 1950–2050. Population Studies, 207. New York: Department of Economic and Social Affairs. Population Division. 2002.Google Scholar
  204. United Nations. World Population Prospects. The 2015 Revision. Key Findings and Advance Tables. New York, NY: United Nations. 2015.Google Scholar
  205. U.S. Centers for Medicare & Medicaid Services. National Health Expenditure Data. Age and Gender Tables. 2016. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/2012GenderandAgeTables.zip
  206. Wagner, Lisa Smith, and Todd H. Wagner. “The effect of age on the use of health and self-care information: Confronting the stereotype.” The Gerontologist 43, no. 3 (2003): 318–324.CrossRefGoogle Scholar
  207. Walter, Stefan et al. “No evidence of morbidity compression in Spain: A time series study based on national hospitalization records.” International Journal of Public Health 61, no. 7 (2016): 729–738.CrossRefGoogle Scholar
  208. Wang, Haidong and GBD 2015 Mortality and Causes of Death Collaborators. “Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015”. The Lancet 388, no. 10053 (2015): 1459–1544.Google Scholar
  209. Werblow, Andreas, Stefan Felder, and Peter Zweifel. “Population ageing and health care expenditure: A school of ‘red herrings’?” Health Economics 16, no. 10 (2007): 1109–1126.CrossRefGoogle Scholar
  210. Williams, Alan. “Health economics: The cheerful face of the dismal science?” In Health and Economics. Proceedings of Section F (Economics) of the British Association for the Advancement of Science Bristol, 1986. Edited by Alan Williams, 1–11. Basingstoke: Macmillan Press. 1987.CrossRefGoogle Scholar
  211. Wilson, Donna M., and Pedro Palha. “A systematic review of published research articles on health promotion at retirement.” Journal of Nursing Scholarship 39, no. 4 (2007): 330–337.CrossRefGoogle Scholar
  212. World Health Organization. Preamble to the Constitution of the World Health Organization as Adopted by the International Health Conference New York, 19–22 June 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948. 1948.Google Scholar
  213. Xu, Jiaquan. Mortality Among Centenarians in the United States, 2000–2014. NCHS Data Brief 233. Hyattsville, MD. 2016.Google Scholar
  214. Yang, Chung Jen, Ying Che Tsai, and Joseph J. Tien. “The impacts of persistent behaviour and cost-sharing policy on demand for outpatient visits by the elderly: Evidence from Taiwan’s national health insurance.” The Geneva Papers on Risk and Insurance-Issues and Practice 42, no. 1 (2017): 31–52.CrossRefGoogle Scholar
  215. Yee, Barbara W.K., and David A. Chiriboga. “Issues of diversity in health psychology and aging.” In Handbook of Health Psychology and Aging. Edited by Carolyn Aldwin, Crystal L. Park, and Avron Spiro III, 286–312. New York, NY: Guilford Press. 2007.Google Scholar
  216. Younsi, Moheddine, Mohamed Chakroun, and Amine Nafla. “Robust analysis of the de-terminants of healthcare expenditure growth: Evidence from panel data for low-, middle- and high-income countries.” The International Journal of Health Planning and Management 31, no. 4 (2016): 580–601.CrossRefGoogle Scholar
  217. Zhavoronkov, Alex. The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy. New York, NY: St. Martin’s Press. 2013.Google Scholar
  218. Zweifel, Peter. “Supplier-induced demand in a model of physician behavior.” In Health, Economics, and Health Economics. Edited by J. Van der Gaag and M. Perlman, 245–267. Amsterdam: North-Holland. 1981.Google Scholar
  219. Zweifel, Peter. The Theory of Social Health Insurance. Foundations and Trends in Microeconomics. Hanover MA: Now Publishers Inc. 2007.CrossRefGoogle Scholar
  220. Zweifel, Peter, Friedrich Breyer, and Mathias Kifmann. Health Economics, 2nd ed. Heidelberg: Springer. 2009.CrossRefGoogle Scholar
  221. Zweifel, Peter, and Roland Eisen. Insurance Economics. Springer Texts in Business and Economics. Heidelberg: Springer. 2012.CrossRefGoogle Scholar
  222. Zweifel, Peter, Stefan Felder, and Markus Meiers. “Ageing of population and health care expenditure: A red herring?” Health Economics 8, no. 6 (1999): 485–496.CrossRefGoogle Scholar
  223. Zweifel, Peter, Stefan Felder, and Andreas Werblow. “Population ageing and health care expenditure: New evidence on the “red herring”.” The Geneva Papers on Risk and Insurance Issues and Practice 29, no. 4 (2004): 652–666.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2018

Authors and Affiliations

  • José Luis Iparraguirre
    • 1
    • 2
  1. 1.University of MorónBuenos AiresArgentina
  2. 2.Age UKLondonUK

Personalised recommendations